We’ve been talking about VR for voices for more than a decade. Are the results finally catching up with the hype? A new multi-site RCT from Denmark tests a refined, immersive version of AVATAR therapy for people with schizophrenia who continue to hear distressing voices despite medication.
[read the full story...]
What if therapy focused not on thoughts or voices, but on the vivid images that often accompany them? The iMAPS-2 trial tested a novel imagery-focused therapy for psychosis, showing it’s safe, acceptable, and ready for a full-scale trial.
[read the full story...]
Antidepressants can help millions of people recover from depression and anxiety, but how do they affect physical health? Out today, a review in The Lancet compared 30 antidepressants to see which ones are most (and least) likely to increase our risk of heart disease, stroke, diabetes etc.
[read the full story...]
A large multicentre trial from Germany found that repetitive Transcranial Magnetic Stimulation (rTMS) significantly reduced auditory hallucinations compared to sham treatment. Could this safe and well-tolerated therapy finally offer new hope for people with persistent voices?
[read the full story...]
A large NHS trial found that the Circle of Security parenting programme did not outperform treatment-as-usual for parents experiencing perinatal mental health difficulties. But does this mean we should stop offering it?
[read the full story...]
The UPSIDES trial demonstrates that peer support is effective across diverse global contexts, from high-income to low-income countries. While overall social inclusion scores didn’t reach significance, participants showed reduced isolation and increased empowerment and hope. This landmark study proves peer support can be successfully adapted to different cultural settings while maintaining core recovery-oriented principles.
[read the full story...]
Despite psychedelics’ roots in Indigenous and minoritised communities, clinical trials overwhelmingly centre White participants. This review highlights the consequences and asks how research can change.
[read the full story...]
Despite psychedelics’ deep ties with queer culture, research often excludes queer voices. This recent scoping review highlights gaps and shows how inclusive, intersectional methods can transform the field.
[read the full story...]
Inflammation is a key factor in depression for many people. This new RCT used an experimental immune challenge to explore how individuals with high inflammation respond differently—shedding light on a distinct biological subtype of depression.
[read the full story...]
Despite strong evidence, collaborative care remains underused in the NHS. This blog explores new findings that highlight which components of the model are most effective in reducing depression symptoms.
[read the full story...]
